Evaluating biocompatibility for medical devices, medical products, and their materials is critical for understanding biological safety and potential product liability risk — particularly under recent increasing scrutiny from regulatory agencies, recalls, and litigation. As the complexity and functionality of medical products continue to advance and include more materials, regulators continue to focus on biocompatibility as a key requirement.
In his upcoming PLAC webinar, Exponent Biomedical Engineering & Sciences Principal Engineer Kevin Ong, Ph.D., P.E., along with Butler Snow attorney Chad Hutchison, will discuss the impact biocompatibility for medical devices and medical products bears on product liability and how to mitigate risks.
"Human Body Meets Medical Device: Are We Biocompatible?"
TUESDAY, SEPT. 12 | 2:00 P.M. EDT
Speakers: Kevin Ong, Ph.D., P.E., Chad Hutchinson, Esq.
This webinar will provide a brief overview of how biocompatibility is assessed, recent FDA activities pertaining to material safety research, and strategies to addressing biological safety in product liability litigation. Those working in the life sciences arena can leverage this information in mitigating risks during material selection and biological assessment of their medical products, as well as understand how biocompatibility can impact product liability risk.